167 related articles for article (PubMed ID: 31952963)
1. Neutral analogs of the heat shock protein 70 (Hsp70) inhibitor, JG-98.
Shao H; Gestwicki JE
Bioorg Med Chem Lett; 2020 Mar; 30(5):126954. PubMed ID: 31952963
[TBL] [Abstract][Full Text] [Related]
2. Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein-Protein Interactions with Heat Shock Protein 70 (Hsp70).
Shao H; Li X; Moses MA; Gilbert LA; Kalyanaraman C; Young ZT; Chernova M; Journey SN; Weissman JS; Hann B; Jacobson MP; Neckers L; Gestwicki JE
J Med Chem; 2018 Jul; 61(14):6163-6177. PubMed ID: 29953808
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of heat shock protein 70 (Hsp70) with enhanced metabolic stability reduce tau levels.
Shao H; Li X; Hayashi S; Bertron JL; Schwarz DMC; Tang BC; Gestwicki JE
Bioorg Med Chem Lett; 2021 Jun; 41():128025. PubMed ID: 33839251
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces tau levels.
Miyata Y; Li X; Lee HF; Jinwal UK; Srinivasan SR; Seguin SP; Young ZT; Brodsky JL; Dickey CA; Sun D; Gestwicki JE
ACS Chem Neurosci; 2013 Jun; 4(6):930-9. PubMed ID: 23472668
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a novel thioflavin S-derived compound that inhibits BAG-1-mediated protein interactions and targets BRAF inhibitor-resistant cell lines.
Enthammer M; Papadakis ES; Salomé Gachet M; Deutsch M; Schwaiger S; Koziel K; Ashraf MI; Khalid S; Wolber G; Packham G; Cutress RI; Stuppner H; Troppmair J
Mol Cancer Ther; 2013 Nov; 12(11):2400-14. PubMed ID: 24048738
[TBL] [Abstract][Full Text] [Related]
6. Affinity-based protein profiling identifies vitamin D3 as a heat shock protein 70 antagonist that regulates hedgehog transduction in murine basal cell carcinoma.
Wen J; Hadden MK
Eur J Med Chem; 2022 Jan; 228():114005. PubMed ID: 34844141
[TBL] [Abstract][Full Text] [Related]
7. Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2-Depleted Splice Variant of Aminoacyl-Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70.
Kim DG; Huddar S; Lim S; Kong J; Lee Y; Park CM; Lee S; Suh YG; Kim M; Lee K; Lee S; Kim S
J Pharmacol Exp Ther; 2021 Dec; 379(3):358-371. PubMed ID: 34503993
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity of (E)-2-benzothiazole hydrazones.
Lindgren EB; de Brito MA; Vasconcelos TR; de Moraes MO; Montenegro RC; Yoneda JD; Leal KZ
Eur J Med Chem; 2014 Oct; 86():12-6. PubMed ID: 25147145
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives as Selective PI3Kβ Inhibitors.
Cao S; Cao R; Liu X; Luo X; Zhong W
Molecules; 2016 Jul; 21(7):. PubMed ID: 27384552
[TBL] [Abstract][Full Text] [Related]
10. Designing Specific HSP70 Substrate Binding Domain Inhibitor for Perturbing Protein Folding Pathways to Inhibit Cancer Mechanism.
Coşkun KA; Koca İ; Gümüş M; Tutar Y
Anticancer Agents Med Chem; 2021; 21(11):1472-1480. PubMed ID: 32951578
[TBL] [Abstract][Full Text] [Related]
11. Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations.
Yaglom JA; Wang Y; Li A; Li Z; Monti S; Alexandrov I; Lu X; Sherman MY
Sci Rep; 2018 Feb; 8(1):3010. PubMed ID: 29445088
[TBL] [Abstract][Full Text] [Related]
12. Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents.
Li X; Srinivasan SR; Connarn J; Ahmad A; Young ZT; Kabza AM; Zuiderweg ER; Sun D; Gestwicki JE
ACS Med Chem Lett; 2013 Nov; 4(11):1042-7. PubMed ID: 24312699
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and structure-activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents.
Ma J; Chen D; Lu K; Wang L; Han X; Zhao Y; Gong P
Eur J Med Chem; 2014 Oct; 86():257-69. PubMed ID: 25171780
[TBL] [Abstract][Full Text] [Related]
14. [Design, synthesis and activities of novel benzothiazole derivatives containing arylpiperazine].
Liu WH; Chang JX; Liu Y; Luo JW; Zhang JW
Yao Xue Xue Bao; 2013 Aug; 48(8):1259-65. PubMed ID: 24187833
[TBL] [Abstract][Full Text] [Related]
15. Regulating the cytoprotective response in cancer cells using simultaneous inhibition of Hsp90 and Hsp70.
Wang Y; McAlpine SR
Org Biomol Chem; 2015 Feb; 13(7):2108-16. PubMed ID: 25526223
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitors.
Bhuva HA; Kini SG
J Mol Graph Model; 2010 Aug; 29(1):32-7. PubMed ID: 20493747
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel pyrimidine-based benzothiazole derivatives as potent cyclin-dependent kinase 2 inhibitors with anticancer activity.
Diao PC; Lin WY; Jian XE; Li YH; You WW; Zhao PL
Eur J Med Chem; 2019 Oct; 179():196-207. PubMed ID: 31254921
[TBL] [Abstract][Full Text] [Related]
18. Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins.
Tang G; Nikolovska-Coleska Z; Qiu S; Yang CY; Guo J; Wang S
J Med Chem; 2008 Feb; 51(4):717-20. PubMed ID: 18237106
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of benzothiazole derivatives bearing the ortho-hydroxy-N-acylhydrazone moiety as potent antitumor agents.
Ma J; Zhang G; Han X; Bao G; Wang L; Zhai X; Gong P
Arch Pharm (Weinheim); 2014 Dec; 347(12):936-49. PubMed ID: 25230149
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Hsp70-Bag3 protein-protein interaction as a potential therapeutic target in cancer.
Li X; Colvin T; Rauch JN; Acosta-Alvear D; Kampmann M; Dunyak B; Hann B; Aftab BT; Murnane M; Cho M; Walter P; Weissman JS; Sherman MY; Gestwicki JE
Mol Cancer Ther; 2015 Mar; 14(3):642-8. PubMed ID: 25564440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
